Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Agnosia 4Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pain, Postoperative 2Neoplasms 2Uveal Melanoma 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain 1Opioid-Related Disorders 1Mucositis 1Mouth Neoplasms 1Melanoma 1Intra-abdominal Cancer 1Ileus 1Goiter 1Eye Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Cancer Pain 1Brain Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Tramadol × Clear all
NCT07110051 2025-08-11

Nalbuphine Versus Tramadol on Post Operative Analgesia in Abdominal Surgery on Pediatric Cancer Patient

National Cancer Institute, Egypt

Phase NA Recruiting
128 enrolled
Tumor-Agnostic

Neoplasms

NCT04613830 2023-02-03

Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

Assiut University

Phase 3 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡